RankAlpha logo
Back to Rankings

ORMP

OramedF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
Bull case assumes positive clinical/regulatory outcomes and at least one commercial partnership that validates the oral-protein delivery platform and materially expands addressable market, justifying a significant multiple re-rate and >70% upside from the anchor. Reviewer note: recent aggregator snippets show consensus targets near $3.25–3.32 (sanity check vs.
Posture
Defensive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite.
What can break
Clinical trial failure or negative data
Momentum
13
Value
44
Sentiment
27
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $3.30 · Bull $6.00 · Bear $1.80Analysis 2026-01-09; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-08 • Model: HYBRID_IC_RP
AI Memo
As of 2026-01-09 • Model: RankAlpha Sentiment AI
Investment thesis
As of 2026-09-08

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-08. Definitions

Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $7.00
Why
Momentum13 · Δ7d -
Value44 · Δ7d -0.0
Sentiment27 · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.

Confirming evidence

  • Sentiment remains the lead driver in the composite.

Contradictions & invalidation

  • Clinical trial failure or negative data
  • Competitive advances in oral biologics delivery
  • Bear case assumes failed pivotal readouts or inability to commercialize the platform without dilutive financing, returning the equity toward prior lows and steep downside (~45–55%).

Catalyst clock

2026-04-09

Next quarterly/earnings update

Lead driver: Sentiment · See AI snapshot
Momentum
13
9% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
44
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
27
62% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade

Composite grade F. Momentum 13.1 / Value 44.4 / Sentiment 26.8

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-01-09. Scenario method

B+
Bull case
20%
Probability
Target price
$6.00
Analysis reference price unavailable
Analysis 2026-01-09 · RankAlpha Sentiment AI
Most likely
B
Base case
55%
Probability
Target price
$3.30
Analysis reference price unavailable
Analysis 2026-01-09 · RankAlpha Sentiment AI
B-
Bear case
25%
Probability
Target price
$1.80
Analysis reference price unavailable
Analysis 2026-01-09 · RankAlpha Sentiment AI
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$190.1M
Beta
1.33
Shares Out
41.6M
P/E (TTM)
2.9
P/S (TTM)
58.91
P/FCF (TTM) · Derived
-33.04
Rev YoY
-100.0%
EPS YoY
+489.6%
Gross Margin
-5.4%
Op Margin
-650.5%
Net Debt
-$125.07M
Current Ratio
4.98
As of 2026-09-08 • Updated nightlySource: Internal modelMethods & Data